BioCryst Pharmaceuticals
BCRX
#4706
Rank
โ‚ฌ1.49 B
Marketcap
7,21ย โ‚ฌ
Share price
1.43%
Change (1 day)
54.07%
Change (1 year)

Revenue for BioCryst Pharmaceuticals (BCRX)

Revenue in 2024 (TTM): โ‚ฌ0.35 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.35 Billion. In 2023 the company made a revenue of โ‚ฌ0.29 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ0.25 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioCryst Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.35 B18.18%
2023 โ‚ฌ0.29 B18.74%
2022 โ‚ฌ0.25 B81.93%
2021 โ‚ฌ0.13 B858.34%
2020 โ‚ฌ14.48 M-66.78%
2019 โ‚ฌ43.59 M141.47%
2018 โ‚ฌ18.05 M-13.99%
2017 โ‚ฌ20.99 M-16.22%
2016 โ‚ฌ25.05 M-43.23%
2015 โ‚ฌ44.13 M294.45%
2014 โ‚ฌ11.18 M-10.84%
2013 โ‚ฌ12.54 M-36.86%
2012 โ‚ฌ19.87 M31.41%
2011 โ‚ฌ15.12 M-67.75%
2010 โ‚ฌ46.89 M-9.92%
2009 โ‚ฌ52.06 M28.68%
2008 โ‚ฌ40.45 M-17.07%
2007 โ‚ฌ48.78 M936.52%
2006 โ‚ฌ4.7 M3571.61%
2005 โ‚ฌ0.12 M1853.77%
2004 โ‚ฌ0 M-99.49%
2003 โ‚ฌ1.29 M-23.55%
2002 โ‚ฌ1.69 M-86.56%
2001 โ‚ฌ12.63 M944.39%
2000 โ‚ฌ1.2 M-54.8%
1999 โ‚ฌ2.67 M-51.88%
1998 โ‚ฌ5.56 M450%
1997 โ‚ฌ1.01 M-53.85%
1996 โ‚ฌ2.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.55 B 57.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.39 B 293.73%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.72 B 105.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.75 B 7,173.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.69 M-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.28 B 10,430.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.99 B 181.08%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA